American Journal of Respiratory and Critical Care Medicine
| 短名 | |
| Journal Impact | 19.35 |
| 国际分区 | RESPIRATORY SYSTEM(Q1) |
| 期刊索引 | SCI Q1中科院 1 区 |
| ISSN | 1073-449X, 1535-4970 |
| h-index | 423 |
| 国内分区 | 医学(1区)医学危重病医学(1区)医学呼吸系统(1区) |
| Top期刊 | 是 |
《美国呼吸与重症监护医学杂志》专注于人类生物学和疾病，以及有助于了解影响呼吸系统和危重病人的疾病的病理生理学和治疗的动物和体外研究。主要以细胞和分子生物学为基础的论文发表在配套期刊《美国呼吸细胞和分子生物学杂志》上。该杂志还寻求以多种形式发表有关感兴趣领域的临床试验和优秀评论文章。最先进的评论是一篇论文，通常涵盖一个广泛的领域，将基准研究带到床边。较短的评论以重症监护观点或肺部观点发表。这些通常集中在更有限的领域，并就特定过程的护理提出一致意见。简明临床评论提供了基于证据的文献综合，这些文献涉及对肺、重症监护和睡眠医学实践具有根本重要性的主题。为该领域提供进步或不寻常贡献的图像以“肺、重症监护、睡眠医学和科学中的图像”的形式发布。
期刊主页投稿网址| 涉及主题 | 医学内科学生物病理免疫学心理学化学哲学遗传学外科精神科语言学肺重症监护医学生物化学麻醉物理内分泌学地理放射科 |
| 出版信息 | 出版商: American Thoracic Society，出版周期: Semimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1994，原创研究文献占比: 96.00%，自引率:5.70%， Gold OA占比: 25.57% |
| 平均审稿周期 | 网友分享经验：一般,3-6周 |
| 平均录用比例 | 网友分享经验：很难 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Inhibiting iNKT Cell Activation: A Promising Strategy Against Pulmonary Fibrosis
2024-9-13
Erratum: Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease
2024-9-13
Reply to Yasuma <i>et al.</i>: Inhibiting iNKT Cell Activation: A Promising Strategy Against Pulmonary Fibrosis
2024-9-13
Temporal Exploration of COPD Phenotypes: Insights from the COPDGene and SPIROMICS Cohorts
2024-9-13
September 15 Highlight
2024-9-13
The Road Less Traveled: Slow but Steady Progress Toward Cystic Fibrosis Gene Therapy by UK Respiratory Gene Therapy Consortium
2024-9-12
Are We Getting Closer to the “Cholesterol” for Chronic Respiratory Disease?
2024-9-12
The Role of ICS in Reducing Cardiovascular Risk - Seeing Is Not Always Believing
2024-9-10
Proteomic Risk Score of Increased Respiratory Susceptibility: A Multi-Cohort Study
2024-9-10
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-In-Human Trial
2024-9-5
Paradigm Shift in ICU Candidacy for Allogeneic Hematopoietic Stem-Cell Transplantation: Who, When, and How Long?
2024-9-5
What Harm Are We Doing to Our Patients with Asthma by Using High-Dose Inhaled Corticosteroids?
2024-9-3
September 1 Highlight
2024-9-1
Erratum: Shift-Level Team Familiarity Is Associated with Improved Outcomes in Mechanically Ventilated Adults
2024-9-1
Physiologic Effects of ECMO in Patients with Severe Acute Respiratory Distress Syndrome
2024-9-1
Erratum: Serum Cell-Free DNA-based Detection of <i>Mycobacterium avium</i> Complex Infection
2024-9-1
Erratum: Missing Funder in “17q21 Variants Disturb Mucosal Host Defense in Childhood Asthma”
2024-8-30
Reply to Yoshihiro and Taito: True Effect of Fludrocortisone for Septic Shock: Baseline Risk and Transitivity Concerns
2024-8-30
Reply to Verbanck and Vanderhelst: Towards Realistic Longitudinal Monitoring of Structure-Function in Smokers
2024-8-30
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in COPD: A Post-hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)
2024-8-30
Tiny Particles, Big Health Impacts
2024-8-30
Towards Realistic Longitudinal Monitoring of Structure-Function in Smokers
2024-8-30
True Effect of Fludrocortisone for Septic Shock: Baseline Risk and Transitivity Concerns
2024-8-30
The Need for Biomarkers Common to Blood and Lung Tissue in Emphysema: Anyone Would Rather Give You a Blood Sample than a Lung Sample
2024-8-28
IL-22Ra2 Levels Remain Elevated in People with Cystic Fibrosis Despite Modulator Therapy
2024-8-28
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces <i>Aspergillus fumigatus</i> in Cystic Fibrosis
2024-8-27
Toll-like Receptor 9 Inhibition Mitigates Fibroproliferative Responses in Translational Models of Pulmonary Fibrosis
2024-8-27
Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine Among Critically Ill Patients
2024-8-22
A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat Tuberculosis
2024-8-22
Is Pulmonary Vascular Resistance in ARDS the Judge Defining Recruitment versus Overdistention with PEEP?
2024-8-21
The Emperor’s New Clothes Revisited
2024-8-21
Reply to Glanville: The Emperor’s New Clothes Revisited
2024-8-21
August 15 Highlight
2024-8-15
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Study
2024-8-15
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
2024-8-15
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine
2024-8-15
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the <i>AJRCCM</i> Special Issue on ILD (Part 2)
2024-8-15
Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2<sup>nd</sup> International Post-Tuberculosis Symposium
2024-8-14
Reply to Yu <i>et al.</i>: Elevated Suicide Risk in Idiopathic Pulmonary Fibrosis Patients
2024-8-14
Elevated Suicide Risk in Idiopathic Pulmonary Fibrosis Patients
2024-8-14
Nanoplastics in the Human Respiratory System
2024-8-13
Progressive Early Interstitial Lung Abnormalities in Persons At-Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study
2024-8-13
Reply to Bihari <i>et al.</i>: Alveolar Collapse Is a Threat in Injured Lungs but What About the Airway Opening Pressure
2024-8-12
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene
2024-8-12
Delayed Tuberculosis Paradoxical Reaction Associated with TNF Inhibitors
2024-8-12
A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease. An Official American Thoracic Society Research Statement
2024-8-12
Alveolar Collapse Is a Threat in Injured Lungs but What About the Airway Opening Pressure
2024-8-12
Air Pollution and Bronchitis: Childhood Exposure, Lifelong Consequences
2024-8-12
Who Benefits from Mechanical Circulatory Support?
2024-8-12
Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement
2024-8-8
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远